Natera, Inc., a global leader in cell-free DNA testing, and Neon Therapeutics, Inc., a clinical-stage immuno-oncology company developing neoantigen-based therapeutics.....
Business Wire Cambridge, Mass., Has successfully completed an extension of $ 36 million in Series B financing, plus the $ 70 million announced. In January 2017, the total funding for this round B transaction reached $ 106 million.